Increasing antigenicity of B16 melanoma cell fraction with microwave hyperthermia

Area of Science:

• Immunology
• Oncology
• Biophysics

Background:

• B16 melanoma is a common murine model for studying cancer immunology.
• Microwave hyperthermia is a physical therapy modality with potential anti-cancer effects.
• Understanding immune system modulation in cancer is crucial for developing novel therapies.

Purpose of the Study:

• To investigate the immunomodulatory effects of a specific fraction derived from microwave-treated B16 melanoma cells.
• To evaluate the therapeutic potential of this fraction in a murine melanoma model.

Main Methods:

• B16 melanoma cells were subjected to microwave hyperthermia (2450 MHz, 44°C for 20 minutes).
• A fraction (C30 mw) was isolated from the homogenate via centrifugation.
• C57-BL/6J male mice were injected with the C30 mw fraction, followed 26 days later by inoculation with viable B16 melanoma cells.

Main Results:

• Injection of the C30 mw fraction significantly increased the survival time of mice inoculated with B16 melanoma cells (p < 0.01).
• The observed survival benefit correlated with increased immunoglobulin synthesis in the protected mice.
• Mice injected with untreated tumor cell fractions or viable tumor cells exhibited earlier mortality (p < 0.001), suggesting immune inhibition.

Conclusions:

• A fraction derived from microwave-treated B16 melanoma cells possesses immunotherapeutic properties.
• This fraction enhances the host's humoral immunity, leading to improved survival against melanoma challenge.
• The findings suggest a novel approach to cancer immunotherapy by utilizing physically modified tumor-derived fractions.